Legal Representation
Attorney
MARGARET M. POWERS
USPTO Deadlines
Next Deadline
1884 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250225)
Due Date
February 25, 2031
Grace Period Ends
August 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 25, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 25, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 3, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 3, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 3, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 3, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 3, 2025 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 3, 2025 | SNEA | W | SU-EXAMINER'S AMENDMENT WRITTEN | Loading... |
| Jan 30, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 13, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 29, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 13, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 9, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 9, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 4, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 4, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 18, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 16, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 16, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 16, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 6, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 18, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 13, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 28, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 28, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 28, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 28, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Nov 28, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 17, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 10, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 10, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 10, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 20, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Medical cost management; Pharmaceutical cost management services and drug utilization review services
First Use Anywhere:
Dec 15, 2018
First Use in Commerce:
Nov 1, 2020
Additional Information
Pseudo Mark
DSR - DRUGS AND SAVINGS REPORT
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DRUGS & SAVINGS REPORT"